ACM
PRAX icon

ACT Capital Management’s Praxis Precision Medicines PRAX Stock Holding History

ACT Capital Management’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$904K Hold
2,700
– – 0.59% 27
2026
Q1 		$870K Buy
2,700
+2,000
+286% +$619K 0.68% 19
2025
Q4 		$206K Buy
+700
New +$130K 0.17% 44

Other funds holding PRAX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
MAP
Moody Aldrich Partners Marblehead, Massachusetts $557M AUM 122.79% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
SO
STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

ACT Capital Management's PRAX Position: Q2 2026 in Review

ACT Capital Management held its Praxis Precision Medicines (PRAX) position steady in Q2 2026 at 2,700 shares worth $904K. The position accounts for 0.59% of the portfolio, ranked #27.

ACT Capital Management first reported a position in PRAX in Q4 2025 and has held it in 3 quarters since. 40 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

  • ACT Capital Management held 2,700 shares of Praxis Precision Medicines worth $904K as of Q2 2026.
  • ACT Capital Management left its Praxis Precision Medicines share count unchanged in Q2 2026.
  • Praxis Precision Medicines made up 0.59% of ACT Capital Management's portfolio in Q2 2026, its #27 holding.
  • ACT Capital Management first reported a position in Praxis Precision Medicines in Q4 2025 and has held it in 3 quarters since.
  • 40 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on ACT Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.